These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 8437860

  • 1. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
    Gutmann DH, Boguski M, Marchuk D, Wigler M, Collins FS, Ballester R.
    Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
    [Abstract] [Full Text] [Related]

  • 2. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N, Ricca C, Fletcher J, Glover T, Seizinger BR, Manne V.
    Cancer Res; 1995 Aug 15; 55(16):3569-75. PubMed ID: 7627966
    [Abstract] [Full Text] [Related]

  • 3. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S, Maekawa M, Nakamura S.
    Oncogene; 1992 Mar 15; 7(3):481-5. PubMed ID: 1549362
    [Abstract] [Full Text] [Related]

  • 4. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
    Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, Camonis J, Wigler M, Collins FS.
    Mol Cell Biol; 1993 Jan 15; 13(1):487-95. PubMed ID: 8417346
    [Abstract] [Full Text] [Related]

  • 5. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
    Marshall MS, Hettich LA.
    Oncogene; 1993 Feb 15; 8(2):425-31. PubMed ID: 8426748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neurofibromatosis type 1 gene mutations in neuroblastoma.
    The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF, Bernards A.
    Nat Genet; 1993 Jan 15; 3(1):62-6. PubMed ID: 8490657
    [Abstract] [Full Text] [Related]

  • 9. Structural analysis of the GAP-related domain from neurofibromin and its implications.
    Scheffzek K, Ahmadian MR, Wiesmüller L, Kabsch W, Stege P, Schmitz F, Wittinghofer A.
    EMBO J; 1998 Aug 03; 17(15):4313-27. PubMed ID: 9687500
    [Abstract] [Full Text] [Related]

  • 10. Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras.
    Scheffzek K, Lautwein A, Kabsch W, Ahmadian MR, Wittinghofer A.
    Nature; 1996 Dec 12; 384(6609):591-6. PubMed ID: 8955277
    [Abstract] [Full Text] [Related]

  • 11. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B, Bollag G, Shannon K.
    Am J Med Genet; 1999 Mar 26; 89(1):14-22. PubMed ID: 10469432
    [Abstract] [Full Text] [Related]

  • 12. Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras.
    Schweins T, Geyer M, Kalbitzer HR, Wittinghofer A, Warshel A.
    Biochemistry; 1996 Nov 12; 35(45):14225-31. PubMed ID: 8916907
    [Abstract] [Full Text] [Related]

  • 13. Structure and function of p21 ras proteins.
    Shih TY, Hattori S, Clanton DJ, Ulsh LS, Chen ZQ, Lautenberger JA, Papas TS.
    Gene Amplif Anal; 1986 Nov 12; 4():53-72. PubMed ID: 3333361
    [Abstract] [Full Text] [Related]

  • 14. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK, Cannon JF.
    Oncogene; 1996 Sep 19; 13(6):1209-20. PubMed ID: 8808695
    [Abstract] [Full Text] [Related]

  • 15. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
    Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F.
    Cell; 1990 Nov 16; 63(4):851-9. PubMed ID: 2121371
    [Abstract] [Full Text] [Related]

  • 16. A yeast GTPase-activating protein that interacts specifically with a member of the Ypt/Rab family.
    Strom M, Vollmer P, Tan TJ, Gallwitz D.
    Nature; 1993 Feb 25; 361(6414):736-9. PubMed ID: 8441469
    [Abstract] [Full Text] [Related]

  • 17. Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein.
    DiBattiste D, Golubic M, Stacey D, Wolfman A.
    Oncogene; 1993 Mar 25; 8(3):637-43. PubMed ID: 8437847
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.
    Xu H, Gutmann DH.
    Brain Res; 1997 Jun 06; 759(1):149-52. PubMed ID: 9219873
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.
    Nishi T, Lee PS, Oka K, Levin VA, Tanase S, Morino Y, Saya H.
    Oncogene; 1991 Sep 06; 6(9):1555-9. PubMed ID: 1923522
    [Abstract] [Full Text] [Related]

  • 20. [NF1 (neurofibromatosis type 1)].
    Maruta H, Nur-e-Kamal.
    Gan To Kagaku Ryoho; 1997 Sep 06; 24(11):1422-6. PubMed ID: 9309135
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.